First-in-human biodistribution and first PET imaging results of [Ga-68]EMP-100 in metastatic renal cell carcinoma

Conclusion of the Independent study carried out by LMU Munich, Germany

 

Visualization of c-MET expression with 68Ga-EMP-100 PET imaging allows for clinicopathological staging in mRCC and has potential as a predictive biomarker of targeted therapies.